{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:21:08Z","timestamp":1791476468862,"version":"4.3.4"},"reference-count":154,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Knee osteoarthritis (KOA) is the most common form of joint degeneration with increasing prevalence and incidence in recent decades. KOA is a molecular disorder characterized by the interplay of numerous molecules, a considerable number of which can be detected in body fluids, including synovial fluid, urine, and blood. However, the current diagnosis and treatment of KOA mainly rely on clinical and imaging manifestations, neglecting its molecular pathophysiology. The mismatch between participants\u2019 molecular characteristics and drug therapeutic mechanisms might explain the failure of some disease-modifying drugs in clinical trials. Hence, according to the temporal alteration of representative molecules, we propose a novel molecular classification of KOA divided into pre-KOA, early KOA, progressive KOA, and end-stage KOA. Then, progressive KOA is furtherly divided into four subtypes as cartilage degradation-driven, bone remodeling-driven, inflammation-driven, and pain-driven subtype, based on the major pathophysiology in patient clusters. Multiple clinical findings of representatively investigated molecules in recent years will be reviewed and categorized. This molecular classification allows for the prediction of high-risk KOA individuals, the diagnosis of early KOA patients, the assessment of therapeutic efficacy, and in particular, the selection of homogenous patients who may benefit most from the appropriate therapeutic agents.<\/jats:p>","DOI":"10.3389\/fcell.2021.725568","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T11:50:38Z","timestamp":1630669838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":93,"title":["Molecular Classification of Knee Osteoarthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhongyang","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick Xiaofan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Ikegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongquan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","article-title":"Leptin in the interplay of inflammation, metabolism and immune system disorders.","volume":"13","author":"Abella","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mad.2019.01.004","article-title":"Resistin: a reappraisal.","volume":"178","author":"Acquarone","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbm.a.35601","article-title":"Synthesis of self-assembled IL-1Ra-presenting nanoparticles for the treatment of osteoarthritis.","volume":"104","author":"Agarwal","year":"2016","journal-title":"J. Biomed. Mater. Res. A"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-018-2143-2","article-title":"A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients \u2013 ZAP2.","volume":"19","author":"Aitken","year":"2018","journal-title":"BMC Musculoskelet. Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/bmc-2019-0014","article-title":"Advances in molecular biomarker for early diagnosis of osteoarthritis.","volume":"10","author":"Akul","year":"2019","journal-title":"Biomol. Concepts"},{"key":"B6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","article-title":"IL-17 signaling: the Yin and the Yang.","volume":"38","author":"Amatya","year":"2017","journal-title":"Trends Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/art.38856","article-title":"Association between experimental pain biomarkers and serologic markers in patients with different degrees of painful knee osteoarthritis.","volume":"66","author":"Arendt-Nielsen","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/art.30360","article-title":"Increased interleukin-1\u03b2 gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis.","volume":"63","author":"Attur","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B9","article-title":"The combination of an inflammatory peripheral blood gene expression and imaging biomarkers enhance prediction of radiographic progression in knee osteoarthritis.","volume":"21","author":"Attur","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.joca.2015.08.006","article-title":"Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis.","volume":"23","author":"Attur","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B11","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.joca.2010.09.014","article-title":"Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis \u2013 meta-analysis.","volume":"19","author":"Bannuru","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"B13","first-page":"6511","article-title":"MiRNA-210: a current overview.","volume":"37","author":"Bavelloni","year":"2017","journal-title":"Anticancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.joca.2014.11.005","article-title":"Effects of total and regional fat loss on plasma CRP and IL-6 in overweight and obese, older adults with knee osteoarthritis.","volume":"23","author":"Beavers","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.joca.2013.08.014","article-title":"Synovial fluid levels of bradykinin correlate with biochemical markers for cartilage degradation and inflammation in knee osteoarthritis.","volume":"21","author":"Bellucci","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"B16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/annrheumdis-2019-216296","article-title":"Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.","volume":"79","author":"Berenbaum","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/bor.0b013e32835a9414","article-title":"Osteoarthritis, inflammation and obesity.","volume":"25","author":"Berenbaum","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-204698","article-title":"Signature of circulating microRNAs in osteoarthritis.","volume":"74","author":"Beyer","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1987-7","article-title":"Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis.","volume":"21","author":"Bihlet","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.freeradbiomed.2018.08.038","article-title":"Reactive oxygen species, aging and articular cartilage homeostasis.","volume":"132","author":"Bolduc","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/jama.2020.2938","article-title":"Effect of intravenous zoledronic acid on tibiofemoral cartilage volume among patients with knee osteoarthritis with bone marrow lesions: a randomized clinical trial.","volume":"323","author":"Cai","year":"2020","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1136\/annrheumdis-2019-215325","article-title":"Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: data from the Osteoarthritis Initiative.","volume":"78","author":"Camacho-Encina","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rheumatology\/ket247","article-title":"Osteoarthritis: a progressive disease with changing phenotypes.","volume":"53","author":"Casta\u00f1eda","year":"2014","journal-title":"Rheumatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.joca.2008.02.008","article-title":"The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation.","volume":"16","author":"Charni-Ben Tabassi","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"B25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/ard.2006.065904","article-title":"Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis.","volume":"66","author":"Christensen","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"B26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jor.23720","article-title":"Mechanically stimulated biomarkers signal cartilage changes over 5 years consistent with disease progression in medial knee osteoarthritis patients.","volume":"36","author":"Chu","year":"2018","journal-title":"J. Orthop. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.7326\/m19-0675","article-title":"Disease-modifying effects of a novel cathepsin K inhibitor in osteoarthritis.","volume":"172","author":"Conaghan","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1586\/eci.10.48","article-title":"At the crossroad between immunity and metabolism: focus on leptin.","volume":"6","author":"Conde","year":"2010","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1006\/cyto.2000.0818","article-title":"Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells.","volume":"13","author":"Constantinescu","year":"2001","journal-title":"Cytokine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/b978-0-12-821039-0.00003-4","article-title":"Obesity, inflammation, and the gut microbiota.","volume":"3","author":"Cox","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/art.39006","article-title":"Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis.","volume":"67","author":"Daghestani","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.joca.2005.06.014","article-title":"One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression.","volume":"13","author":"Deberg","year":"2005","journal-title":"Osteoarthritis Cartilage"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191045","article-title":"Classification of patients with knee osteoarthritis in clinical phenotypes: data from the osteoarthritis initiative.","volume":"13","author":"Dell\u2019Isola","year":"2018","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1056\/NEJMoa1905877","article-title":"Physical therapy versus glucocorticoid injection for osteoarthritis of the knee.","volume":"382","author":"Deyle","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00264-015-2744-4","article-title":"Calcitonin gene-related peptide can be selected as a predictive biomarker on progression and prognosis of knee osteoarthritis.","volume":"39","author":"Dong","year":"2015","journal-title":"Int. Orthop."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/art.40826","article-title":"Accelerated knee osteoarthritis is characterized by destabilizing meniscal tears and preradiographic structural disease burden.","volume":"71","author":"Driban","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1007\/s10067-016-3299-5","article-title":"Defining and evaluating a novel outcome measure representing end-stage knee osteoarthritis: data from the Osteoarthritis Initiative.","volume":"35","author":"Driban","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/s2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis.","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrrheum.2012.69","article-title":"Meniscus pathology, osteoarthritis and the treatment controversy.","volume":"8","author":"Englund","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.659654","article-title":"Macro, micro, and molecular. Changes of the osteochondral interface in osteoarthritis development.","volume":"9","author":"Fan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/0003-4819-139-5_part_1-200309020-00008","article-title":"Bone marrow edema and its relation to progression of knee osteoarthritis.","author":"Felson","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/art.40840","article-title":"A phase II trial of lutikizumab, an anti\u2013interleukin-1\u03b1\/\u03b2 dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis.","volume":"71","author":"Fleischmann","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2013-203954","article-title":"Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.","volume":"74","author":"Fransen","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cytogfr.2011.04.003","article-title":"Crosstalk between cartilage and bone: when bone cytokines matter.","volume":"22","author":"Funck-Brentano","year":"2011","journal-title":"Cytokine Growth Fact. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.joca.2019.12.012","article-title":"The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort.","volume":"28","author":"Garnero","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051314","article-title":"Novel ex vivo human osteochondral explant model of knee and spine osteoarthritis enables assessment of inflammatory and drug treatment responses.","volume":"19","author":"Geurts","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1749-6632.2009.05240.x","article-title":"Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis.","volume":"1192","author":"Goldring","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1136\/ard.2006.053272","article-title":"Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade.","volume":"65","author":"Grunke","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.joca.2015.04.018","article-title":"Severe radiographic knee osteoarthritis\u2013does Kellgren and Lawrence grade 4 represent end stage disease?\u2013the MOST study.","volume":"23","author":"Guermazi","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.joca.2018.08.003","article-title":"Modeling and predicting osteoarthritis progression: data from the osteoarthritis initiative.","volume":"26","author":"Halilaj","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"B51","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.joca.2019.01.001","article-title":"Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis.","volume":"27","author":"He","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-309","article-title":"Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammation.","volume":"15","author":"He","year":"2014","journal-title":"BMC Musculoskelet. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/jor.22297","article-title":"Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study.","volume":"31","author":"Henrotin","year":"2013","journal-title":"J. Orthop. Res."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1177\/1947603519878489","article-title":"Serum levels of Coll2-1, a specific biomarker of cartilage degradation, are not affected by sampling conditions, circadian rhythm, and seasonality.","author":"Hick","year":"2019","journal-title":"Cartilage"},{"key":"B55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/annrheumdis-2014-206792","article-title":"Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.","volume":"75","author":"Hochberg","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/annrheumdis-2020-218089","article-title":"Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis.","volume":"80","author":"Hu","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrrheum.2015.158","article-title":"Does lipopolysaccharide-mediated inflammation have a role in OA?","volume":"12","author":"Huang","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.joca.2016.05.008","article-title":"Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation.","volume":"24","author":"Huang","year":"2016","journal-title":"Osteoarthritis Cartilage"},{"key":"B59","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis.","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/genes12070989","article-title":"Synovium-synovial fluid axis in osteoarthritis pathology: a key regulator of the cartilage degradation process.","volume":"12","author":"Ingale","year":"2021","journal-title":"Genes (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/14712598.2017.1271873","article-title":"Tanezumab in the treatment of chronic musculoskeletal conditions.","volume":"17","author":"Jayabalan","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/annrheumdis-2013-204494","article-title":"Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis.","volume":"74","author":"Jin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.joca.2018.08.019","article-title":"CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial.","volume":"26","author":"Jin","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"B64","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/11599350-000000000-00000","article-title":"Role of interleukin-1 inhibitors in osteoarthritis.","volume":"29","author":"Jotanovic","year":"2012","journal-title":"Drugs Aging"},{"key":"B65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","article-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.","volume":"23","author":"Karsdal","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B67","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.joca.2012.02.644","article-title":"Sex dimorphism in the association of cardiometabolic characteristics and osteophytes-defined radiographic knee osteoarthritis among obese and non-obese adults: NHANES III.","volume":"20","author":"Karvonen-Gutierrez","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"B68","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00421-006-0362-y","article-title":"Biomarkers of muscle and cartilage damage and inflammation during a 200 km run.","volume":"99","author":"Kim","year":"2007","journal-title":"Eur. J. Appl. Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1016\/j.clinthera.2009.12.016","article-title":"Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, phase IV study in Korean patients.","volume":"31","author":"Kim","year":"2009","journal-title":"Clin. Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3109\/1354750x.2015.1105498","article-title":"Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women.","volume":"20","author":"Kluzek","year":"2015","journal-title":"Biomarkers"},{"key":"B71","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/acr.24131","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of osteoarthritis of the hand, hip, and knee.","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Care Res."},{"key":"B72","first-page":"2852","article-title":"Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis.","volume":"9","author":"Kong","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.joca.2015.03.036","article-title":"Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B74","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","article-title":"Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium.","volume":"76","author":"Kraus","year":"","journal-title":"Ann. Rheum. Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/annrheumdis-2016-209253","article-title":"Establishment of reference intervals for osteoarthritis-related soluble biomarkers: the FNIH\/OARSI OA Biomarkers Consortium.","volume":"76","author":"Kraus","year":"","journal-title":"Ann. Rheum. Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.joca.2019.08.003","article-title":"The role of leptin and adiponectin as mediators in the relationship between adiposity and hand and knee osteoarthritis.","volume":"27","author":"Kroon","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"B77","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.joca.2013.03.008","article-title":"Diagnostic and prognostic value of bone biomarkers in progressive knee osteoarthritis: a 6-year follow-up study in middle-aged subjects.","volume":"21","author":"Kumm","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.joca.2019.07.009","article-title":"Type II collagen peptide Coll2-1 is an actor of synovitis.","volume":"27","author":"Lambert","year":"2019","journal-title":"Osteoarthritis Cartilage"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.joca.2015.05.035","article-title":"Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy.","volume":"23","author":"Larsson","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B80","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/0363546516666818","article-title":"A multicenter study of early anti-inflammatory treatment in patients with acute anterior cruciate ligament tear.","volume":"45","author":"Lattermann","year":"2016","journal-title":"Am. J. Sports Med."},{"key":"B81","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/acr.20373","article-title":"Pain sensitivity and pain reactivity in osteoarthritis.","volume":"63","author":"Lee","year":"2011","journal-title":"Arthritis Care Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/jci14452","article-title":"Autoantibodies as predictors of disease.","volume":"108","author":"Leslie","year":"2001","journal-title":"J. Clin. Invest."},{"key":"B83","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/jmri.24313","article-title":"Quantitative MRI of articular cartilage and its clinical applications.","volume":"38","author":"Li","year":"2013","journal-title":"J. Magn. Reson. Imaging"},{"key":"B84","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1497-4","article-title":"Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711.","volume":"16","author":"Lindstr\u00f6m","year":"2018","journal-title":"J. Transl. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1148\/radiol.2262012190","article-title":"Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings.","volume":"226","author":"Link","year":"2003","journal-title":"Radiology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.12659\/msm.893771","article-title":"Correlation of IL-17 level in synovia and severity of knee osteoarthritis.","volume":"21","author":"Liu","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/art.24598","article-title":"Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford Study.","volume":"60","author":"Livshits","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ.","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B89","article-title":"Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.","volume":"15","author":"Lugo","year":"2016","journal-title":"Nutr. J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.metabol.2018.03.018","article-title":"The vitamin D receptor regulates miR-140-5p and targets the MAPK pathway in bone development.","volume":"85","author":"Luo","year":"2018","journal-title":"Metabolism"},{"key":"B91","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00167-011-1743-2","article-title":"Definition and classification of early osteoarthritis of the knee.","volume":"20","author":"Luyten","year":"2012","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"B92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3892\/etm.2014.2071","article-title":"Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear \u03baB ligand.","volume":"9","author":"Lv","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"B93","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00167-016-4068-3","article-title":"Early osteoarthritis of the knee.","volume":"24","author":"Madry","year":"2016","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107553","article-title":"Targeting neurotrophic factors: novel approaches to musculoskeletal pain.","volume":"211","author":"Malfait","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B95","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.72","article-title":"Osteoarthritis.","volume":"2","author":"Martel-Pelletier","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1001\/jama.2017.5283","article-title":"Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial.","volume":"317","author":"McAlindon","year":"2017","journal-title":"JAMA"},{"key":"B97","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0140-6736(20)30564-X","article-title":"Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.","volume":"395","author":"McInnes","year":"2020","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00011-007-7204-1","article-title":"Knee osteoarthritis: a role for bradykinin?","volume":"57","author":"Meini","year":"2008","journal-title":"Inflamm. Res."},{"key":"B99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2011.10.003","article-title":"The diagnostic performance of MRI in osteoarthritis: a systematic review and meta-analysis.","volume":"20","author":"Menashe","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"B100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/BOR.0000000000000354","article-title":"Nerve growth factor blockade for the management of osteoarthritis pain: what can we learn from clinical trials and preclinical models?","volume":"29","author":"Miller","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"B101","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.joca.2016.12.016","article-title":"Osteoarthritis year in review 2016: biomarkers (biochemical markers).","volume":"25","author":"Mobasheri","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"B102","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1002\/art.25014","article-title":"Denuded subchondral bone and knee pain in persons with knee osteoarthritis.","volume":"60","author":"Moisio","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B103","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1515\/hsz-2016-0280","article-title":"\u03b2-NGF and \u03b2-NGF receptor upregulation in blood and synovial fluid in osteoarthritis.","volume":"398","author":"Montagnoli","year":"2017","journal-title":"Biol. Chem."},{"key":"B104","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijbiomac.2019.03.234","article-title":"Chondroprotective action of glucosamine, a chitosan monomer, on the joint health of athletes.","volume":"132","author":"Nagaoka","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"B105","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis.","volume":"21","author":"Neogi","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"B106","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.rehab.2016.02.008","article-title":"Evidence and recommendations for use of intra-articular injections for knee osteoarthritis.","volume":"59","author":"Nguyen","year":"2016","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"B107","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.joca.2017.01.002","article-title":"Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA.","volume":"25","author":"Nwosu","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"B108","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.amjopharm.2012.09.004","article-title":"Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics.","volume":"10","author":"O\u2019Neil","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10121016","article-title":"Positive association of serum alkaline phosphatase level with severe knee osteoarthritis: a nationwide population-based study.","volume":"10","author":"Park","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"B110","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.matbio.2018.02.023","article-title":"Cartilage oligomeric matrix protein: COMPopathies and beyond.","volume":"7","author":"Posey","year":"2018","journal-title":"Matrix Biol."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072358","article-title":"The role of chondrocyte hypertrophy and senescence in osteoarthritis initiation and progression.","volume":"21","author":"Rim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis.","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2020192498","article-title":"State of the art: imaging of osteoarthritis-revisited 2020.","volume":"296","author":"Roemer","year":"2020","journal-title":"Radiology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41584-018-0010-z","article-title":"The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA.","volume":"14","author":"Roemer","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/nu11092027","article-title":"Effectiveness of non-animal chondroitin sulfate supplementation in the treatment of moderate knee osteoarthritis in a group of overweight subjects: a randomized, double-blind, placebo-controlled pilot study.","volume":"11","author":"Rondanelli","year":"2019","journal-title":"Nutrients"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2086-5","article-title":"Association of circulating microRNAs with prevalent and incident knee osteoarthritis in women: the OFELY study.","volume":"22","author":"Rousseau","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"B117","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/1947603515586048","article-title":"Pre-osteoarthritis: definition and diagnosis of an elusive clinical entity.","volume":"6","author":"Ryd","year":"2015","journal-title":"Cartilage"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/annrheumdis-2013-203260","article-title":"Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis.","volume":"73","author":"Sagar","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1007\/s00167-019-05614-z","article-title":"Early knee osteoarthritis prevalence is highest among middle-aged adult females with obesity based on new set of diagnostic criteria from a large sample cohort study in the Japanese general population.","volume":"28","author":"Sasaki","year":"2020","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.joca.2009.02.011","article-title":"Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease.","volume":"17","author":"Scanzello","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1097\/j.pain.0000000000001625","article-title":"Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety.","volume":"160","author":"Schmelz","year":"2019","journal-title":"Pain"},{"key":"B122","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMcp1903768","article-title":"Osteoarthritis of the knee.","volume":"384","author":"Sharma","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1001-9294(17)30002-0","article-title":"Expression of miRNA-140 in chondrocytes and synovial fluid of knee joints in patients with osteoarthritis.","volume":"31","author":"Si","year":"2016","journal-title":"Chin. Med. Sci. J."},{"key":"B125","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.omtn.2019.10.032","article-title":"miR-140 attenuates the progression of early-stage osteoarthritis by retarding chondrocyte senescence.","volume":"19","author":"Si","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B126","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.joca.2013.10.020","article-title":"Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover.","volume":"22","author":"Siebuhr","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01016","article-title":"Biomarkers in painful symptomatic knee OA demonstrate that MRI assessed joint damage and type II collagen degradation products are linked to disease progression.","volume":"13","author":"Sofat","year":"2019","journal-title":"Front. Neurosci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/art.22005","article-title":"Estradiol and its metabolites and their association with knee osteoarthritis.","volume":"54","author":"Sowers","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B129","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1210\/edrv-14-4-424","article-title":"Molecular mechanisms mediating proliferation\/differentiation interrelationships during progressive development of the osteoblast phenotype.","volume":"14","author":"Stein","year":"1993","journal-title":"Endocr. Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.joca.2018.06.005","article-title":"Changes in synovial fluid and serum concentrations of cartilage oligomeric matrix protein over 5 years after anterior cruciate ligament rupture: an exploratory analysis in the KANON trial.","volume":"26","author":"Struglics","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"B131","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1155\/2013\/176278","article-title":"Serum interleukin-15 levels are associated with severity of pain in patients with knee osteoarthritis.","volume":"35","author":"Sun","year":"2013","journal-title":"Dis. Markers"},{"key":"B132","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-00852-1","article-title":"Small-volume detection: platform developments for clinically-relevant applications.","volume":"19","author":"Sung","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"B133","first-page":"40","article-title":"The function of microRNAs in cartilage and osteoarthritis.","author":"Swingler","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"B134","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s10067-016-3170-8","article-title":"Is blood neutrophil-lymphocyte ratio an independent predictor of knee osteoarthritis severity?","volume":"35","author":"Ta\u015fo\u011flu","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2011-201177","article-title":"Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis.","volume":"72","author":"van Spil","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.joca.2019.11.007","article-title":"Osteoarthritis year in review 2019: biomarkers (biochemical markers).","volume":"28","author":"van Spil","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.joca.2012.08.001","article-title":"Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK.","volume":"20","author":"Van Spil","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"B138","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/BOR.0000000000000479","article-title":"Epidemiology of osteoarthritis: literature update.","volume":"30","author":"Vina","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1074-7613(09)00091-0","article-title":"Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.","volume":"14","author":"Waldmann","year":"2001","journal-title":"Immunity"},{"key":"B140","doi-asserted-by":"publisher","first-page":"7986","DOI":"10.1523\/JNEUROSCI.2393-05.2005","article-title":"Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission.","volume":"25","author":"Wang","year":"2005","journal-title":"J. Neurosci."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02156-5","article-title":"Post-traumatic osteoarthritis following ACL injury.","volume":"22","author":"Wang","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.joca.2017.09.007","article-title":"Safety, tolerability, and pharmacodynamics of an anti-interleukin-1\u03b1\/\u03b2 dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study.","volume":"25","author":"Wang","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"B143","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrrheum.2012.224","article-title":"Tackling obesity in knee osteoarthritis.","volume":"9","author":"Wluka","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"B144","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1045-7","article-title":"Are estrogen-related drugs new alternatives for the management of osteoarthritis?","volume":"18","author":"Xiao","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-019-0868-z","article-title":"Adipokines: new therapeutic target for osteoarthritis?","volume":"21","author":"Xie","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7165406","article-title":"Synovial fluid microRNA-210 as a potential biomarker for early prediction of osteoarthritis.","volume":"2019","author":"Xie","year":"2019","journal-title":"Biomed Res. Int."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007593","article-title":"Comparative study of CTX-II, Zn2+, and Ca2+ from the urine for knee osteoarthritis patients and healthy individuals.","volume":"96","author":"Xin","year":"2017","journal-title":"Medicine"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.bbamem.2015.02.004","article-title":"Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain.","volume":"1848","author":"Yoneda","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-020-00109-x","article-title":"Classification of four distinct osteoarthritis subtypes with a knee joint tissue transcriptome atlas.","volume":"8","author":"Yuan","year":"2020","journal-title":"Bone Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/ard.2010.131904","article-title":"Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review.","volume":"70","author":"Yusuf","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.14336\/AD.2019.1116","article-title":"Infrapatellar fat pad and knee osteoarthritis.","volume":"11","author":"Zeng","year":"2020","journal-title":"Aging Dis."},{"key":"B152","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.joca.2020.01.007","article-title":"Macrophages regulate the progression of osteoarthritis.","volume":"28","author":"Zhang","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"B153","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/art.30148","article-title":"Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging.","volume":"63","author":"Zhang","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.joca.2015.04.002","article-title":"CCL3 serves as a potential plasma biomarker in knee degeneration (osteoarthritis).","volume":"23","author":"Zhao","year":"2015","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.725568\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T18:36:58Z","timestamp":1725734218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.725568\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":154,"alternative-id":["10.3389\/fcell.2021.725568"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.725568","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]},"article-number":"725568"}}